Hao, Yang
Chung, Chih Kit
Gu, Zili
Schomann, Timo
Dong, Xiaoxu
Veld, Ruben V. Huis in ‘t
Camps, Marcel G. M.
ten Dijke, Peter
Ossendorp, Ferry A.
Cruz, Luis J.
Funding for this research was provided by:
Cancer Genomics Centre Netherlands
VIDI personal grant (project number 723.012.110 L.J.C)
Marie Sklodowska Curie grant (No 777682 (CANCER), 734684 (CHARMED), 872391 (CONCRETE), PRISAR2 (872860); ACORN (807281), SIMICA (852985), 952520 (BIOSAFETY), 675743 (ISPIC))
China Scholarship Council (CSC201806170106, CSC201906100211)
Article History
Received: 5 March 2022
Accepted: 2 June 2022
First Online: 17 August 2022
Declarations
:
: This study was performed in line with the principles of the Dutch Animal Ethical Commission with the license of project AVD116008045 and approved by the Animal Experimental Committee from the Leiden University Medical Center (LUMC).
: All authors reviewed the data and consented to submission.
: The authors declare no conflicts of interest. The funders, JeNaCell GmbH and Percuros B.V. had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.